No association of CCR5D32 gene mutation with multiple sclerosis in Croatian and Slovenian patients

Abstract

Several studies investigating the role of the CCR5D32 mutation in multiple sclerosis (MS) have reported varied, often contradictory results. Therefore in the present study we have analysed whether the CCR5D32 mutation is associated with the risk of/or disease process in Croatian and Slovene MS patients. Three hundred and twenty-five MS patients and 356 healthy controls were genotyped by the polymerase chain reaction method. Our results showed no significant differences in the distribution of CCR5D32 mutations between MS and control subjects, indicating that this mutation does not influence susceptibility to MS. Furthermore, we did not observe that CCR5D32 carrier-status could modulate age of disease onset or progression of the disease. It is therefore our conclusion that the present study indicates that the CCR5D32 mutation is neither protective of, nor a risk factor, for MS development.

Keywords

CCR5 polymorphism multiple sclerosis susceptibility gene

Get full access to this article

View all access options for this article.

References

Bennetts BH , Teutsch SM , Buhler MM , Heard RN , Stewart GJ. The CCR5 deletion mutation fails to protect against multiple sclerosis . Hum Immunol 1997; 58: 52-59 .

Sellebjerg F , Madsen HO , Jensen CV , Jensen J , Garred P. CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis . J Neuroimmunol 2000; 102: 98-106 .

Barcellos LF , Schito AM , Rimmler JB , Vittinghoff E , Shih A , Lincoln R et al. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis . Immunogenetics 2000; 51: 281-288 .

Kantor R , Bakhanashvili M , Achiron A. A mutated CCR5 gene may have favorable prognostic implications in MS . Neurology 2003; 61: 238-240 .

Pulkkinen K , Luomala M , Kuusisto H , Lehtimaki T , Saarela M , Jalonen TO et al. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis . Acta Neurol Scand 2004; 109: 342-347 .

Favorova OO , Andreewski TV , Boiko AN , Sudomoina MA , Alekseenkov AD , Kulakova OG et al. The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians . Neurology 2002; 59: 1652-1655 .

Silversides JA , Heggarty SV , McDonnell GV , Hawkins SA , Graham CA. Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course . Mult Scler 2004; 10: 149-152 .

Gade-Andavolu R , Comings DE , MacMurray J , Rostamkhani M , Cheng LS , Tourtellotte WW et al. Association of CCR5 delta32 deletion with early death in multiple sclerosis . Genet Med 2004: 6: 126-131 .

Lublin FD , Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey . Neurology 1996; 46: 907-911 .

10.

Roxburgh RH , Seaman SR , Masterman T , Hensiek AE , Sawcer SJ , Vukusic S et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity . Neurology 2005; 64: 1144-1151 .